✦ LIBER ✦

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

✍ Scribed by Thomsen, Henrik S.; Morcos, Sameh K.; Almén, Torsten; Bellin, Marie-France; Bertolotto, Michele; Bongartz, Georg; Clement, Olivier; Leander, Peter; Heinz-Peer, Gertraud; Reimer, Peter; Stacul, Fulvio; Molen, Aart; Webb, Judith AW

Book ID: 118781929
Publisher: Springer
Year: 2012
Tongue: English
Weight: 238 KB
Volume: 23
Category: Article
ISSN: 0938-7994
DOI: 10.1007/s00330-012-2597-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ESUR guideline: gadolinium-based contras

ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis

✍ Henrik S. Thomsen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 77 KB

Biochemical safety profiles of gadoliniu

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis

✍ Hale Ersoy; Frank J. Rybicki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side

Is there a causal relation between the a

Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

✍ H.S. Thomsen; S.K. Morcos; P. Dawson 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB